Abandoned bones suggest TB wiped out leprosy in battle of killer diseasesFebruary 07, 2005The spread of tuberculosis may have killed off leprosy in Europe in the Middle Ages, according to research published in the latest issue of the Royal Society Proceedings B. A collaborative study led by University College London (UCL) scientists, following the discovery of a shrouded body in a sealed chamber overlooked by tomb robbers, found evidence of both diseases in a range of archaeological remains dating from the 1st to the 15th centuries. An initial examination of the body, currently under analysis in Israel, revealed signs of co-infection of TB and leprosy in the bone tissue. The collaborative team, led by Dr Helen Donoghue and Dr Mark Spigelman from UCL's Centre for Infectious Diseases and International Health, went on to identify co-infection in ancient bones around Europe, where the DNA of the bacteria behind both diseases was detected in 42 per cent of the samples examined.
In the Middle Ages leprosy was a widespread, much-feared disease which unaccountably declined around the same time that tuberculosis began to spread across Europe. TB went on to become a major long-term epidemic disease, with one-third of the world's population now infected and more than 8 million new cases in the year 2000 alone. Researchers now believe that the two trends were no coincidence. In fact, the new findings suggest that TB overtook leprosy as the more aggressive, faster-killing disease. Dr Mark Spigelman says: "We stumbled across this discovery while examining a shrouded body excavated by Israeli archaeologist Dr Shimon Gibson. The body from around Jerusalem dated from the 1st century AD, when the normal burial practice was to wrap it in a shroud, then return after a suitable time and rebury the bones in an ossuary". "In this case, the shrouded body had not been re-buried. We thought there must have been a reason for this, so we decided to look for signs of leprosy - a cause of fear and stigma at the time - in addition to the tuberculosis which we had already found to be present". Dr Helen Donoghue says: "After finding both diseases in the body, we re-examined other samples from sites around ancient and mediaeval Europe and realized that we were looking at a fairly common, previously unrecognised phenomenon of co-infection". "Scientists have previously speculated over whether cross-immunity might have protected tuberculosis patients from leprosy. However, our findings suggest a different explanation". "A weakening of the immune system following infection by leprosy, coupled with the stress, poverty and malnutrition associated with the social isolation and stigma of living with the disease, could have paved the way for opportunistic co-infection by TB which brought a speedier death. In time this would reduce the number of individuals suffering from leprosy, leading to its overall decline." University College London - UCL | |||||||||||||||||||||
|
Related Tuberculosis News Articles New method to overcome multiple drug resistant diseases developed by Stanford researchers Many drugs once considered Charles Atlases of the pharmaceutical realm have been reduced to the therapeutic equivalent of 97-pound weaklings as the diseases they once dispatched with ease have developed resistance to them. India continues to progress in AIDS vaccine development efforts A second Phase I AIDS vaccine clinical trial in India was successfully completed, the Indian Council of Medical Research, the National AIDS Control Organization and the International AIDS Vaccine Initiative announced. The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated. Extensively drug-resistant tuberculosis found in California In the first statewide study of extensively drug-resistant tuberculosis (XDR TB) in the United States, California officials have identified 18 cases of the dangerous and difficult-to-treat disease between 1993 and 2006, and 77 cases that were one step away from XDR TB. The study appears in the August 15 issue of Clinical Infectious Diseases, now available online. Comprehensive treatment of extensively drug-resistant TB works, study finds The death sentence that too often accompanies a diagnosis of extensively drug-resistant tuberculosis (XDR-TB) can be commuted if an individualized outpatient therapy program is followed - even in countries with limited resources and a heavy burden of TB. Treatment outcomes highlight dangers of extensively drug-resistant tuberculosis In a retrospective study of 174 tuberculosis patients treated at National Jewish Health (formerly National Jewish Medical and Research Center), patients with extensively-drug-resistant tuberculosis (XDR-TB) were almost eight times as likely to die as patients with multi-drug resistant tuberculosis (MDR-TB). Ben-Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia A professor at The Faculty of Health Sciences at Ben-Gurion University of the Negev (BGU) is beginning an intensive program in Ethiopia this August to eradicate intestinal worms which affect as much as 50 percent of the population in Africa. Certain HIV treatment less effective when used with anti-TB therapy Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy. Study helps identify which populations of foreign-born persons living in US at higher risk of TB The relative yield of finding and treating latent tuberculosis is particularly high among higher-risk groups of foreign-born persons living in the U.S., such as individuals from most countries of sub-Saharan Africa and Southeast Asia. Tuberculosis presents major challenges to HIV treatment in developing countries Human immunodeficiency virus (HIV) care and treatment programs in resource-limited settings must aggressively address tuberculosis (TB) and the emerging multidrug-resistant TB epidemic to save patient lives and to curb the global TB burden, a major cause of death for persons with HIV. Bovine tuberculosis in wildlife threatens endangered lynx and cattle health In an epidemiological survey of Spain's Doñana National Park, the findings of which are published on July 23 in the journal PLoS ONE, Christian Gortázar and colleagues studied the prevalence of bovine tuberculosis (bovine TB) infection among populations of wild boar, red deer and fallow deer in the national park, which is located in southern Spain. More Tuberculosis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||